On the topic of standards and regulations, what has it been like to work with regulatory agencies such as the FDA and EMA (European Medicines

“Data! Data! Data! I can’t make bricks without clay.” This famous quote from Sherlock Holmes summarizes Dr. Terenzio Ignoni’s outlook on the future of drug

Give him the data, give him the facts, and Dr. Terenzio Ignoni will run with them. As the SVP of Technical Operations, Terenzio is in

We’re back with Ana Maria Garcia-Collazo, Ph.D. of Gain Therapeutics.  We ended Part 1 of our interview talking about the intersection of chemistry and computational

Wisdom is not hard to come by. Passion and enthusiasm are a different story. On a bright and sunny Thursday morning in April 2023, Ana

Part 2: When we left off speaking to Evan Ballantyne, Gain Therapeutics’ new CFO, he was sharing several stories about industry and career successes. Part

On March 29th 2023, Hartaj Singh (Oppenheimer Senior Research Biotechnology Analyst) moderated a virtual Fireside Chat panel with Xavier Barril, Ph.D. (Gain Therapeutics’ CTO), Brandon

On April 12, 2023, Gain Therapeutics announced Evan Ballantyne as the company’s new Chief Financial Officer. Ballantyne has been around the block. His humble demeanor

On Thursday, April 13, 2023, The Michael J. Fox Foundation (MJFF) announced a historic breakthrough1 in the development of Parkinson’s disease detection and diagnosis. The

Over 200 years ago, Dr. James Parkinson, a neurologist, geologist, and activist, published “An Essay on the Shaking Palsy” in 1817 which described the disease.

  Download : AD PD Infographic

On Wednesday, March 29th, Hartaj Singh (Oppenheimer Senior Research Biotechnology Analyst) moderated a virtual Fireside Chat panel with Gain Therapeutics’ CTO Xavier Barril, Ph.D. and

Virtual Fireside Chat: Computational Biology in Drug Discovery with Gain Therapeutics (GANX) CTO & Two Experts on Wednesday, March 29th at 12:00 p.m. EDT Listen

Download: SEE-Tx® Platform

Download: Lead Program in GBA-Parkinson’s Disease 

You joined Gain Therapeutics in 2020 when it was a private company and played a role in helping to take the company public.  What was

Listen to Podcast Watch the full presentation video of Computational Drug Discovery With Gain Therapeutics Matthias Alder In conversation with Mathias Alder, CEO of Gain

What scientific innovation are you most excited about? Which innovation do you think will have the most impact in the next 20 years? I don’t

Your educational background is in law. What was the trajectory of your career? Well, it was an evolution. Throughout my career, I’ve always been involved

Watch the full presentation video of Jeff Harman with Eric Richman, CEO of Gain Therapeutics: 00:01 I am Jeff Harmon 00:14 Eric Richman 00:19 Gain

Piper Sandler recently published a comprehensive report entitled “Deciphering the Artificial Intelligence / Machine Learning Matrix Code in Biotech.”  Why is this report significant? Technology

The Emerging Life Sciences Summit hosted by Oppenheimer will be on July 20th, 2022 in Montauk, NY.  This yearly conference brings together the who’s who

“While we continue to see exciting advances across the biopharma innovation landscape, sadly, new approaches and therapies for neurodegenerative diseases continue to remain largely elusive

Dr. Manolo Bellotto, General Manager and President of Gain Therapeutics, shares his personal story.  You can follow him on : Twitter : @ManoloBellotto LinkedIn : https://www.linkedin.com/in/manolobellotto/

We sat down and got a chance to speak with the General Manager and President of Gain Therapeutics, Dr. Manolo Bellotto. You can follow him